National Health Investors Reports Strong Q4 2025 Results and Positive 2026 Guidance
summarizeSummary
National Health Investors released its Q4 2025 results and initial 2026 guidance, showcasing strong SHOP segment growth, active investment pipeline, and a solid balance sheet with significant liquidity.
check_boxKey Events
-
Strong Q4 2025 Financial Performance
Lease revenue (excluding certain items) increased 7.2% to $67.2 million compared to Q4 2024. The Senior Housing Operating Portfolio (SHOP) segment saw its NOI surge by 124.9% year-over-year to $7.3 million, driven by recent property transitions and acquisitions.
-
Initial 2026 Financial Guidance Issued
The company provided 2026 guidance, projecting NAREIT FFO per diluted share between $4.94 and $4.99, and Normalized FFO per diluted share also between $4.94 and $4.99. This guidance assumes $230 million in new investments and $111.3 million in dispositions.
-
Active Investment and Disposition Strategy
NHI announced $392.4 million in investments during 2025, with an additional $105.5 million SHOP investment in February 2026. The company has signed Letters of Intent (LOIs) totaling $110.6 million and is evaluating a pipeline of $488.0 million in investment opportunities.
-
Strengthened Balance Sheet and Liquidity
Net Debt to Adjusted EBITDA stands at 3.8x, well within the updated target range of 3.5x – 4.5x. Total liquidity was approximately $0.9 billion at December 31, 2025, including $44.5 million available from ATM forward sales agreements and $496.0 million in revolver capacity. NHI settled approximately 0.6 million shares for proceeds of $46.2 million during the quarter.
auto_awesomeAnalysis
National Health Investors (NHI) has provided a comprehensive investor update, detailing robust Q4 2025 financial performance and outlining optimistic guidance for 2026. The company demonstrated significant growth in its Senior Housing Operating Portfolio (SHOP) segment, with NOI increasing 124.9% year-over-year in Q4 2025. NHI also highlighted its active investment strategy, deploying substantial capital in 2025 and announcing further acquisitions in early 2026, supported by a strong pipeline. The balance sheet remains healthy with leverage within target ranges and ample liquidity, partially bolstered by recent At-The-Market (ATM) share settlements. The 2026 guidance, including FFO per share, provides a clear outlook for investors, suggesting continued operational improvements and strategic expansion in a favorable industry environment.
At the time of this filing, NHI was trading at $87.68 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $66.41 to $91.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.